Success (n = 48) | Failure (n = 19) | p-Value | |
---|---|---|---|
Age (years) | 74.1 ± 9.4 | 72.6 ± 8.8 | 0.556 |
Female | 39 (81.3) | 16 (84.2) | 1.000 |
BMI (kg/m2) | 28.1 ± 5.4 | 26.6 ± 3.5 | 0.191 |
Diabetes | 28 (58.3) | 11 (57.9) | 0.974 |
CCI | 3.7 ± 1.6 | 3.5 ± 0.9 | 0.554 |
Symptom duration (days) | 7.6 ± 7.8 | 9.8 ± 9.1 | 0.326 |
Operation | |||
Primary | 44 (92) | 15 (79) | 0.209 |
Revision | 4 (8) | 4 (21) | |
Implant age (Month)* | 17.5 (8.8–47.8) | 12.0 (7.0–38.0) | 0.313 |
Preoperative CRP | 12.3 ± 8.8 | 16.9 ± 13.6 | 0.186 |
Type of organism | |||
Staphylococcus aureus | 10 (20.8) | 5 (26.3) | 0.035 |
Antibiotic-resistant (MRSA, MRSE) | 5 (10.4) | 4 (21.1) | |
Streptococcus | 13 (27.1) | 2 (10.5) | |
Enterococcus | 1 (2.1) | 0 (0.0) | |
Candida | 0 (0.0) | 1 (5.3) | |
Gram negative | 7 (14.6) | 2 (10.5) | |
Polymicrobial | 0 (0.0) | 3 (15.8) | |
Culture negative | 12 (25.0) | 2 (10.5) |